Abstract:
OBJECTIVE:Many observational studies suggest hormone therapy protects against coronary heart disease in contrast to findings from large randomised clinical trials and an observational Danish study. A potential bias in the observational literature concerning the cardiovascular risk and benefits associated with use of hormone therapy is the so-called 'healthy user' phenomenon, i.e. self-selection to HT use is associated with healthier cardiovascular risk profile. This study investigates whether a random sample of Danish women using HT was characterised by a favourable cardiovascular risk profile prior to menopause. METHODS:A sample of 621 women born in 1936 living in Copenhagen County was included in a prospective population-based study initiated in 1976 with follow-ups in 1981, 1987 and 1996. Investigations comprised questionnaires and physical examinations. RESULTS:At 51 and 60 years, respectively, one-third and one-half had ever used HT. At 40 years women who subsequently use HT had lower body mass index, lower self-rated health and lower fasting glucose, but no differences according to blood pressure, cholesterol, triglyceride, physical activity, smoking habits or alcohol consumption. CONCLUSION:In a cohort of Danish women from the general population ever users of HT could not be characterised as unambiguous 'healthy users'.
journal_name
Maturitasjournal_title
Maturitasauthors
Løkkegaard E,Eplov LF,Køster A,Garde Kdoi
10.1016/j.maturitas.2004.05.011keywords:
subject
Has Abstractpub_date
2005-07-16 00:00:00pages
221-6issue
3eissn
0378-5122issn
1873-4111pii
S0378-5122(04)00183-5journal_volume
51pub_type
杂志文章相关文献
MATURITAS文献大全abstract::The increasing lifespan of the world population and the novel therapeutic combinations for the treatment of multiple myeloma (MM), which are more efficacious and safer, make the question of how to manage the older patient with MM increasingly relevant. Clinical trial data come mostly from subgroup analysis, as no clin...
journal_title:Maturitas
pub_type: 杂志文章,评审
doi:10.1016/j.maturitas.2020.04.015
更新日期:2020-08-01 00:00:00
abstract::The specific profile of estrogens on cardiovascular risk, with limiting action on atherogenesis but a less clear protection on cardiovascular episodes, might be improved by other agonists of the estrogen receptor, such as isoflavones. By using a systematic search based on the electronic Medline database plus a hand-se...
journal_title:Maturitas
pub_type: 杂志文章,评审
doi:10.1016/j.maturitas.2010.07.015
更新日期:2010-11-01 00:00:00
abstract:OBJECTIVES:To examine Chinese middle-aged women's health and wellbeing and the associated biosocial correlates. STUDY DESIGN:This study used a cross-sectional design, including selected retrospectively collected information on the final menstrual period, drawn from the 2013 wave of the China Health and Retirement Long...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/j.maturitas.2020.10.008
更新日期:2021-01-01 00:00:00
abstract:OBJECTIVES:To study whether dose adjustments in transdermal estradiol gel treatment would result in proportional changes in estradiol bioavailability and concentrations. METHODS:In an open study, 23 healthy postmenopausal women were treated consecutively with 0.5, 1.0 and 1.5 mg estradiol daily as a transdermal gel. E...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/s0378-5122(00)00101-8
更新日期:2000-04-28 00:00:00
abstract::The recreational use of methamphetamine (METH, or ice) is a global burden. It pervades and plagues contemporary society; it has been estimated that there are up to 35 million users worldwide. METH is a highly addictive psychotropic compound which acts on the central nervous system, and chronic use can induce psychotic...
journal_title:Maturitas
pub_type: 杂志文章,评审
doi:10.1016/j.maturitas.2018.12.003
更新日期:2019-03-01 00:00:00
abstract:OBJECTIVE:To investigate the relationship between the timing of withdrawal bleeding on hormone replacement therapy and the state of the endometrium. DESIGN:Double-blind, prospectively randomised dose-ranging study. SETTING:Menopause clinics in the UK and the Netherlands. SUBJECTS:Two hundred and seventy one postmeno...
journal_title:Maturitas
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1016/s0378-5122(99)00101-2
更新日期:2000-02-15 00:00:00
abstract:OBJECTIVES:Evaluate the association of self-reported vasomotor symptom (VMS) frequency with race/ethnicity among a diverse midlife US population and explore menopause symptom differences by dietary soy isoflavone (genistein+daidzein) consumption. STUDY DESIGN:Cross-sectional population-based study of peri- and postmen...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/j.maturitas.2013.03.003
更新日期:2013-06-01 00:00:00
abstract:BACKGROUND:Estetrol (E4) is a natural estrogen produced solely during human pregnancy. E4 is suitable for clinical use since it acts as a selective estrogen receptor modulator. In clinical trials E4 has been seen to have little or no effect on coagulation. Hence, it is interesting to investigate whether E4 alters endot...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/j.maturitas.2017.02.005
更新日期:2017-05-01 00:00:00
abstract::Gynecological literature is replete with multiple papers on sexually transmitted infections (STIs) in young women. Although those past the reproductive prime may well be at lower risk for STIs than women in the peak reproductive years, STIs are regularly seen in the older cohort and are a cause for significant morbidi...
journal_title:Maturitas
pub_type: 杂志文章,评审
doi:10.1016/j.maturitas.2010.05.003
更新日期:2010-10-01 00:00:00
abstract:OBJECTIVES:The purpose of this study was to determine the frequency with which hormone replacement therapy (HRT) was prescribed and to identify physician-related factors associated with the prescription of HRT in Spain. STUDY DESIGN:A descriptive cross-sectional survey based on a personal interview with a structured q...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/j.maturitas.2006.04.023
更新日期:2006-11-20 00:00:00
abstract:OBJECTIVE:To re-examine the minimal effective dose of conjugated estrogen (CEE)-progestin hormone replacement on postmenopausal bone loss. DESIGN:A 2-year, prospective, open label, randomized study. SETTING:Department of Obstetrics and Gynecology of a university hospital. PARTICIPANTS:Fifty-two postmenopausal or oop...
journal_title:Maturitas
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1016/s0378-5122(97)01110-9
更新日期:1997-05-01 00:00:00
abstract::The present study had two objectives: (1) to register the prevalence of a number of climacteric complaints in a Danish general population cohort and (2) retrospectively to test the validity of an association between climacteric complaints, menopausal development, occurrence of life events and social background. A post...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/0378-5122(93)90043-h
更新日期:1993-11-01 00:00:00
abstract:OBJECTIVES:To review some aspects in the recent literature related to the effects of postmenopausal estrogen and progestin use on major plasma lipoprotein risk factors for coronary heart disease (CHD). METHODS:Collection of relevant information from medical journals, and by the use of Medline and Current Contents. RE...
journal_title:Maturitas
pub_type: 杂志文章,评审
doi:10.1016/0378-5122(96)01012-2
更新日期:1996-05-01 00:00:00
abstract:OBJECTIVE:To compare the effects of (i) continuous low dosage C-19 progestin (dl-norgestrel, NG) plus cyclical conjugated estrogen (CEE) versus (ii) continuous low dosage C-21 progestin [medroxyprogesterone acetate (MPA)] plus CEE on postmenopausal vaginal bleeding, mood and somatic, psychosomatic and psychological sym...
journal_title:Maturitas
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1016/s0378-5122(99)00053-5
更新日期:1999-10-24 00:00:00
abstract:OBJECTIVE:We investigated, using color Doppler ultrasound, possible detectable blood changes of prolonged treatment with 17-beta-estradiol tablets on uterine artery blood flow, in a cohort of low risk postmenopausal women. METHODS:39 postmenopausal women, who were taking local estrogen therapy for at least 6 months, w...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/j.maturitas.2004.07.004
更新日期:2005-04-11 00:00:00
abstract:OBJECTIVE:To examine whether physical activity during the last five years is related to later breast mammographic density in postmenopausal Greek women. METHODS:We designed a cross-sectional study in 724 women, of ages 45-67 years. An interview-administered questionnaire was used to obtain information on duration and ...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/j.maturitas.2011.02.003
更新日期:2011-05-01 00:00:00
abstract:OBJECTIVE:To determine the percentage of endometrial hyperplasia positive for p53 expression in both spontaneously occurring cases or following the use of unopposed estradiol. METHODS:Fifty-four postmenopausal patients with endometrial hyperplasia diagnosed by endometrial biopsy and hysteroscopy were recruited to this...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/s0378-5122(02)00326-2
更新日期:2003-03-28 00:00:00
abstract:OBJECTIVES:To assess the expression of estrogen receptor (ER) in oral mucosa and salivary glands, buccal mucosal biopsies from ten postmenopausal women (taken before and during the hormone replacement therapy), as well as, single biopsies from 20 healthy 19-year-old women were analyzed for ER expression. Salivary gland...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/s0378-5122(00)00138-9
更新日期:2000-08-31 00:00:00
abstract:OBJECTIVE:The aim of this study was to evaluate the effects of different types of hormone replacement therapy (HRT) on mammographic density. MATERIALS AND METHODS:In a prospective 1-year study, 103 postmenopausal women were randomized to receive tibolone 2.5 mg/die, continuous conjugated equine estrogens 0.625 mg/die ...
journal_title:Maturitas
pub_type: 杂志文章,随机对照试验
doi:10.1016/j.maturitas.2005.02.010
更新日期:2006-01-10 00:00:00
abstract::Worldwide, the number of menopausal women is increasing. They present with complex medical issues that lie beyond the traditional scope of gynaecologists and general practitioners (GPs). The European Menopause and Andropause Society (EMAS) therefore provides a holistic model of care for healthy menopause (HM). The HM ...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/j.maturitas.2016.06.018
更新日期:2016-10-01 00:00:00
abstract:OBJECTIVES:Whether menopausal stage is associated with abnormalities in serum lipid and lipoprotein profiles remains unclear; studies have been conducted mostly in Western populations. This study aimed to examine the prevalence of lipid and lipoprotein abnormalities by recently updated menopausal stages in middle-aged ...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/j.maturitas.2014.12.016
更新日期:2015-04-01 00:00:00
abstract::The objective of this systematic review and meta-analysis was to evaluate the efficacy and the effectiveness, as well as the safety and tolerability, of urethral bulking agents (UBAs) in women with mixed or stress urinary incontinence. PubMed, Scopus, and the Cochrane Central Register of Controlled Trials were used to...
journal_title:Maturitas
pub_type: 杂志文章,meta分析
doi:10.1016/j.maturitas.2019.12.007
更新日期:2020-03-01 00:00:00
abstract:OBJECTIVES:The effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with non-insulin dependent diabetes mellitus (type II diabetes) is uncertain. METHODS:The effects of estrogen replacement therapy (ERT, conjugated equine estrogen0.625mg orally daily), combined estrogen and con...
journal_title:Maturitas
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1016/s0378-5122(99)00112-7
更新日期:2000-03-31 00:00:00
abstract:INTRODUCTION:Obesity, defined as an excess of total body fat, is a matter of concern all over the world, and its prevalence is still increasing among elderly people. OBJECTIVES:To examine whether sedentary behaviour (hours sitting per day) is associated with higher risk of central obesity, overweight-obesity and overf...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/j.maturitas.2012.09.001
更新日期:2012-12-01 00:00:00
abstract::Thirty-four post-menopausal women with climacteric complaints were given conjugated equine oestrogens (1.25 mg/day) for 21 days followed by 2 days without hormones and then 5 mg medroxyprogesteroneacetate daily for 5 days. The present trial was designed to study effects on vasomotor symptoms, bleeding patterns and end...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/0378-5122(84)90065-3
更新日期:1984-07-01 00:00:00
abstract:OBJECTIVES:An internet survey was performed to obtain data on the current use in Belgium of hormone replacement therapy and alternative treatments for the alleviation of menopausal symptoms. A supplementary aim was to assess the use of opt-in internet opinion panels (TalkToChange, http://www.talktochange.com, and GMI, ...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/j.maturitas.2016.04.018
更新日期:2016-08-01 00:00:00
abstract:OBJECTIVES:Since the ageing population demands a response to ensure older people remain healthy and active, we studied the dynamics of a recently proposed healthy ageing phenotype. We drew the phenotype's trajectories and tested whether their levels and rates of change are influenced by health behaviours, comorbidities...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/j.maturitas.2016.03.002
更新日期:2016-06-01 00:00:00
abstract::Fifty postmenopausal women requiring hormone replacement therapy for the treatment of climacteric symptoms were recruited in six centers. All patients received a new combined norethisterone acetate (NETA)/oestradiol (E2)-TTS, (Estragest TTS, Ciba-Geigy Ltd), delivering 0.25 mg NETA and 50 micrograms E2 per day, contin...
journal_title:Maturitas
pub_type: 临床试验,杂志文章,多中心研究
doi:10.1016/0378-5122(94)00891-a
更新日期:1995-04-01 00:00:00
abstract:OBJECTIVE:To describe changes in the withdrawal bleeding pattern and endometrial histology during a sequential 17 beta-estradiol-dydrogesterone regimen in postmenopausal women. DESIGN:Open-label, non-comparative, prospective study. SETTING:Gynecological outpatient department of a university hospital. PATIENTS:Twenty...
journal_title:Maturitas
pub_type: 杂志文章
doi:10.1016/0378-5122(94)90014-0
更新日期:1994-12-01 00:00:00
abstract:OBJECTIVE:To study the effects of different types of continuous hormone replacement therapy on carbohydrate metabolism. METHOD:Postmenopausal women were treated with conjugated estrogens, 0.625 mg/medroxyprogesterone acetate, 2.5 or 5 mg (CEE/MPA) or tibolone 2.5 mg daily for 13 28-day cycles. Serum glucose and insuli...
journal_title:Maturitas
pub_type: 杂志文章,多中心研究,随机对照试验
doi:10.1016/j.maturitas.2005.03.003
更新日期:2006-01-10 00:00:00